<?xml version="1.0" encoding="UTF-8"?>
<p id="p0180">In patients with advanced disease complications during drug therapy, serological testing may be more important, because RT-PCR may be false negative as the virus decreases over time [
 <xref rid="bib89" ref-type="bibr">89</xref>]. For epidemiological research, continuous monitoring, vaccine research and risk assessment of potential medical personnel, it is necessary to develop serological tests that can accurately assess previous SARS-CoV-2 infection and immunity. In some countries/regions, immunoassays are already on the market, but their diagnostic reliability and optimal usage are still unclear.
</p>
